Townsend "Questions to Consider..." Flashcards

1
Q

What are the criteria that constitute CKD?

A
  • 3 months of kidney damage
    OR
  • eGFR <60
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the stages of CKD? (eGFR)

A
  • Stage 1: eGFR 90%+
  • Stage 2: eGFR 60-89%
  • Stage 3: eGFR 30-59%
  • Stage 4: eGFR 15-29%
  • Stage 5: eGFR <15%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

At what stage does CKD start to affect the patient’s life?

A
  • Stage 3, most complications start
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are problems/conditions in CKD that affect patient’s life?

A
  • Anemia
  • Bone/Mineral issues
  • CV disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the primary causes of CKD and how best to prevent it?

A
  • T2DM 42%
  • HTN 28%
  • Glomerular Disease 7%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What can be done to slow CKD progression?

A
  • Manage HTN (B/P target < 130/80)
  • ACE-I/ARB for albuminuria and HTN (use in CKD + DM patients)
  • Statin use - reduce vascular events in CKD
  • If DM, A1C <7%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What medications (categories) need to be avoided with CKD (especially = or <30 eGFR)

A
  • NSAIDS
  • Bisphosphonates
  • Metformin
  • Iodine contrast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When do you need to refer patients with CKD to a nephrologist?

A
  • At or before Stage 4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What needs to be part of your treatment monitoring plan with CKD? (Labs specifically)

A
  • Albuminuria: Normal is <30mg/g, Severs > or = 300mg/g
  • Lipids
  • Check UA for low pH, elevated specific gravity, or protein, RBC, WBCs in urine (early signs of complications)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Labs with CKD

Starting by Stage 3

A
  • Serum albumin
  • Phosphorus
  • Calcium
  • Intact Parathyroid Hormone (PTH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dietary considerations with CKD

A
  • Less salt
  • Smaller amounts/right kind of protein
  • Lean meats, skinless chicken, fish, fruits/veggies, beans (heart healthy)
  • Read nutrition labels: watch for high sodium content
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A 50-year old male is diagnosed with CKD. The patient’s recent eGFR was 25 mL/min. What stage of CKD is this known as?

A
  • Stage 4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A 62-year old male has an eGFR of 55 mL/min. Patient has a hx of uncontrolled HTN and CAD. You know what medication might be most helpful in treating both HTN and CKD?

A. Lisinopril
B. Metoprolol
C. Amlodipine
D. Verapamil

A

A. Lisinopril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What constitutes precocious puberty?

A
  • < 8 years old in girls

- <9 years old in boys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What constitutes delayed puberty?

A
  • Girls: no signs by 13 yo or menarche by 16 yo

- Boys: no signs by 14yo or >5 years since 1st sign of puberty w/o additional signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How would you work-up precocious puberty? (labs, x-rays)

A
  • X-ray L hand to determine bone age
  • Labs: LH, FSH, Estradiol/Testosterone
  • If labs show Central PP, order MRI of brain to r/o central lesion of brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What conditions are the most common forms of hypogonadism?

A
  • Girls: Turner syndrome (missing second X chromosome, XO)

- Boys: Klinefelter syndrome (Extra X, XXY)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which of the following diagnostic tests is not likely included as part of the initial evaluation of AUB?

A. Transvaginal US
B. Pregnancy Test
C. TSH
D. CBC
E. MRI
A

E. MRI

19
Q

What are the causes of AUB?

A
- PALM COEIN
Polyp
Adenomyosis
Leiomyoma
Malignancy and Hyperplasia
Coagulopathy
Ovulatory dysfunction
Endometrial
Iatrogenic
Not yet classified
20
Q

Causes of AUB

Polyp

A
  • Intermenstrual bleeding
  • Asymptomatic
  • Dx with sonogram
  • RF = Obesity, HTN, DM, Older age, Tamoxifen use
21
Q

Causes of AUB

Adenomyosis

A
  • Boggy, symmetrical enlarged uterus

- Chronic pain

22
Q

Causes of AUB

Leiomyoma

A
  • AKA Fibroids
  • Benign
  • 80% AA/70% Caucasian
  • Tx: Ulipristol (SPRM), Laproscopic Sx
23
Q

Causes of AUB

Malignancy and Hyperplasia

A
  • Self-explanatory
24
Q

Causes of AUB

Coagulopathy

A
  • 20% of patients
  • Von Willebrand (low levels of clotting factor in blood)
  • Platelet dysfunction
  • Hx of heavy bleeding since menarche
25
Q

Causes of AUB

Ovulatory dysfunction

A
  • MOST COMMON
  • Irregular, short cycle
  • Periods of amenorrhea
  • In Adolescents occurs d/t immature HPO axis -> Anovulation -> Normal physiology that should resolve in 2 years
  • If still persists after 2 years, classify as AUB-E, AUB-I, or AUB-NYC
26
Q

In general, what labs are checked as part of your plan of care for AUB?

A
  • Coag studies (PT/PTT, Fibrinogen, Iron Studies)
  • UPT
  • HcG
  • CBC (check for anemia)
27
Q

What constitutes mild AUB? What is the treatment?

A
  • Duration of HMB < 3 months, Hgb WNL

Treatment:

  • Observe patient
  • Keep menstrual calendar
  • Encourage NSAIDS to reduce menorrhagia
28
Q

What constitutes moderate AUB? What is the treatment?

A
  • Heavy, frequent bleeding q1-3 weeks, Mild anemia

Treatment: Taper monophasic OCP (ethinyl estradiol/norgestrel) + antiemetic – Cycle every 3-6 months

29
Q

What constitutes severe AUB? What is the treatment?

A
  • Heavy, prolonged bleeding, Hgb <9

Treatment:

  • Taper OCP (ethinyl estradiol/norgestrel) q4h til bleeding stops, then use cyclic OCP;
  • Iron Supplement
  • Nausea meds
30
Q

Precocious puberty s/s begin before age __ in girls and before age __ in boys?

A. 8,9
B. 5,6
C. 9,10
D. 8,11

A

A. 8,9

31
Q

What are the recommendations regarding who needs cholesterol medications?

A
  • Clinical ASCVD patients
  • High-risk ASCVD with LDL-C >70mg/dL
  • LDL-C >190mg/dL
  • 40-75 yo + DM + LDL-C > or = 70mg/dL
  • 40-75 yo evaluated for primary ASCVD prevention
  • 40-75 yo w/o DM + LDL-C > or = 70mg/dL + 10 yr ASCVD risk of > or = 7.5%
  • 40-75 yo w/o DM + 10 yr ASCVD risk of 5%-19.9%
  • 40-75 yo w/o DM + LDL-C > or = 70-189mg/dL + 10 yr ASCVD risk of 7.5%-19.9%
  • > 75 yo with LDL-C 70-189mg/dL
32
Q

When should elevated triglycerides be treated with medications?

A
  • Triglycerides > or = 175mg/dL
33
Q

What are non-statin medications and when should they be used?

A
  • Ezetimibe, Bile acid sequestrants, PCSK9 Inhibitors, Niacin, Fibrates
  • In combination with statin or when statins are not tolerated
34
Q

What are the major medication side effects for cholesterol-lowering medications?

A
  • Bilateral myalgia (muscle pain), involving proximal muscles, usually starts w/in weeks to months after starting statin, resolves after d/c of statin
  • HA
  • Dyspepsia
  • Nausea
  • Alopecia
  • ED
  • Myopathy (muscle weakness)
  • Myositis (muscle inflammation)
  • Myonecrosis (muscle wasting)
35
Q

What intensity of statin therapy is required based on risk? What are the medications? Doseages? % of LDL-C reduction?

A
  • High-Intensity
  • Medication: Ator 40-80mg/Rosu 20-40mg
  • % of LDL-C reduction: > or = 50%
  • Mod-Intensity
  • Medication: Ator 10-20mg/Rosu 5-10mg/Sim 20-40mg/Pra 40-80mg/Lov 40mg
  • % of LDL-C reduction: 30-49%
  • Low-Intensity
  • Medication: Sim 10mg/Prav 10-20mg/Lov 20mg/Flu 20-40mg
  • % of LDL-C reduction: <30%
36
Q

What patient risk groups are high and very high risk for ASCVD?

A
  • Smokers
  • HTN
  • Abnormal cholesterol
  • DM
  • Age
37
Q

What statins are high intensity?

A
  • Ator 40-80mg

- Rosu 20-40mg

38
Q

What statins are moderate intensity?

A
  • Ator 10-20mg
  • Rosu 5-10mg
  • Sim 20-40mg
  • Pra 40-80mg
  • Lov 40mg
39
Q

T/F

Most people can lower high cholesterol if they lose weight, eat better, and exercise more.

A

True

40
Q

Who might be a candidate for Ezetimibe?

A
  • Statin Intolerant

- Add to statin if LDL-C stays >70mg/dL

41
Q

Who might be a candidate for PCSK9 inhibitors?

A
  • Statin Intolerant
  • CV risk patients
  • EXPENSIVE!
42
Q

What diet and lifestyle recommendations are encouraged in children/adults with dyslipidemia?

A
  • Veggies/Fruits/Whole Grains
  • Legumes/Nuts
  • Low-fat dairy/poultry
  • Fish/Seafood
  • Non-tropical vegetable oils
43
Q

Are there preferred dosing times for statins?

A
  • Evening
44
Q

Ms. Jones is a 58-year old diabetic patient with hyperlipidemia. Based on this information you would start her out on what statin listed below?

A. No statin, not needed at this time
B. Atorvastatin 40mg
C. Rosuvastatin 40mg
D. Atorvastatin 20mg

A

D. Atorvastatin 20mg